What are you researching?

Supplements for Macular degeneration

Age-related macular degeneration (AMD). Progressive vision loss affecting the central visual field.

Showing 15 of 100 supplements with macular degeneration research
Sort:

AREDS2 formula

AREDS2 Supplement Formula

Specific combination of vitamin C (500mg), vitamin E (400 IU), lutein (10mg), zeaxanthin (2mg), zinc (80mg), and copper (2mg) validated by the NIH-funded AREDS2 trial for slowing AMD progression.

Vision
Dose: Per AREDS2 formula dosing
Macular degeneration
Relevance
High
Evidence
Onset

Copper

Copper (Cupric Oxide)

Essential trace mineral. Included in AREDS2 formula to offset copper depletion from high-dose zinc. Most people get adequate copper from diet.

Immune
Dose: 2 mg/day (AREDS2 dose)
Macular degeneration
Relevance
High
Evidence
Onset

Lutein & Zeaxanthin

Lutein and Zeaxanthin

Carotenoid pigments forming macular pigment that filters blue light and protects photoreceptors. The only carotenoids found in the human lens and retina. AREDS2 validated their role.

CognitionInflammation
Dose: 10 mg lutein + 2 mg zeaxanthin/day
Macular degeneration
Relevance
High
Evidence
Onset

Vitamin C

Ascorbic Acid (Vitamin C)

Essential antioxidant vitamin. Included in AREDS2 formula for AMD. Supports immune function, collagen synthesis, and iron absorption. Megadose claims are largely unsupported.

Immune
Dose: 500 mg/day (AREDS2 dose)
Macular degeneration
Relevance
High
Evidence
Onset

Vitamin E

Alpha-Tocopherol (Vitamin E)

Fat-soluble antioxidant. Part of AREDS2 formula for AMD. SELECT trial raised concerns about prostate cancer risk at high doses. Mixed tocopherols may be safer than alpha-tocopherol alone.

Immune
Dose: 400 IU/day (AREDS2 dose)
Macular degeneration
Relevance
High
Evidence
Onset

Zinc

Zinc (various forms)

Essential trace mineral involved in over 300 enzymatic reactions. Zinc deficiency is linked to tinnitus in multiple studies. Also critical for immune function, wound healing, and retinal health.

TinnitusImmune
Dose: 80 mg zinc oxide/day (AREDS2 dose)
Macular degeneration
Relevance
High
Evidence
Onset

Algal DHA/EPA

Algal Omega-3 (DHA/EPA)

Plant-based source of DHA and EPA from microalgae — the same source fish get their omega-3s from. Suitable for vegetarians/vegans. Equivalent bioavailability to fish oil.

HeartCognition
Dose: 500-1000 mg DHA/day
Macular degeneration
Relevance
Moderate
Evidence
Onset

Astaxanthin

AstaReal

Carotenoid from microalgae — gives salmon and flamingos their color. Estimated 6,000x stronger than vitamin C in singlet oxygen quenching. Crosses blood-brain and blood-retinal barriers.

InflammationImmune
Dose: 4-12 mg/day
Macular degeneration
Relevance
Moderate
Evidence
Onset

Fish oil

Omega-3 Fatty Acids (EPA/DHA)

Essential fatty acids the body cannot produce. EPA and DHA support cardiovascular health, reduce triglycerides, and have anti-inflammatory effects. One of the most studied supplements in existence.

HeartInflammationCognition
Dose: 1-2 g/day
Macular degeneration
Relevance
Moderate
Evidence
Onset

Saffron

Crocus sativus Extract

Expensive spice with surprisingly strong evidence for depression and emerging evidence for AMD. Crocin and safranal are the active compounds. Multiple well-designed RCTs.

CognitionVision
Dose: 20-30 mg/day
Macular degeneration
Relevance
Moderate
Evidence
Onset

Beta-carotene

Beta-Carotene

Provitamin A carotenoid. Was included in original AREDS formula for AMD but removed in AREDS2 due to increased lung cancer risk in smokers. Replaced by lutein/zeaxanthin.

Immune
Dose: Not recommended (replaced by lutein)
Macular degeneration
Relevance
Low
Evidence
Onset

Bilberry

Vaccinium myrtillus Extract

European relative of blueberry. Rich in anthocyanins. WWII-era claims about RAF pilots' night vision drove popularity. Modern evidence is modest for eye health.

Vision
Dose: 80-480 mg standardized extract/day
Macular degeneration
Relevance
Low
Evidence
Onset

Citicoline

Citicoline (CDP-Choline)

Naturally occurring brain compound that provides both choline and cytidine. Supports cell membrane synthesis and neurotransmitter production. Better studied for stroke recovery and cognitive function than most nootropics.

Cognition
Dose: 500-1000 mg/day
Macular degeneration
Relevance
Low
Evidence
Onset

Selenium

Selenium (Selenomethionine)

Essential trace mineral with antioxidant properties. Necessary for thyroid function and glutathione production. Excess can be toxic — narrow therapeutic window.

Cognition
Dose: 55-100 mcg/day
Macular degeneration
Relevance
Low
Evidence
Onset

Vitamin A

Retinol / Beta-Carotene

Essential fat-soluble vitamin for vision, immune function, and cell growth. Preformed vitamin A (retinol) has toxicity risk. Beta-carotene is the safer provitamin A form.

Immune
Dose: Not recommended separately
Macular degeneration
Relevance
Low
Evidence
Onset
How to read the scores

Relevance badges

HighDirectly studied for this condition
ModeratePlausible mechanism
LowWeak or indirect

Evidence & onset bars

Strong evidence / fast onset
Emerging / limited
Insufficient data

Safety strip

No significant concerns
Worth noting
Significant concern
Affiliate links: Same price for you. A small share keeps this site independent.

Beyond supplements

There are other evidence-based interventions studied for macular degeneration:

  • Anti-VEGF injections Standard of care for wet AMD. Dramatically changed outcomes for neovascular disease.
  • Smoking cessation Smoking doubles AMD risk. Cessation is the single most impactful modifiable factor.